These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2161167)

  • 1. Variation in drug-metabolizing enzyme activities during the growth of human Hep G2 hepatoma cells.
    Doostdar H; Demoz A; Burke MD; Melvin WT; Grant MH
    Xenobiotica; 1990 Apr; 20(4):435-41. PubMed ID: 2161167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of culture medium composition on drug metabolising enzyme activities of the human liver derived Hep G2 cell line.
    Doostdar H; Duthie SJ; Burke MD; Melvin WT; Grant MH
    FEBS Lett; 1988 Dec; 241(1-2):15-8. PubMed ID: 2848717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of enzymes involved in metabolism of polycyclic aromatic hydrocarbons among rat liver endomembranes and plasma membranes.
    Stasiecki P; Oesch F; Bruder G; Jarasch ED; Franke WW
    Eur J Cell Biol; 1980 Apr; 21(1):79-92. PubMed ID: 6769676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line.
    Grant MH; Duthie SJ; Gray AG; Burke MD
    Biochem Pharmacol; 1988 Nov; 37(21):4111-6. PubMed ID: 2847753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenobiotic-metabolizing enzymes in human respiratory nasal mucosa.
    Gervasi PG; Longo V; Naldi F; Panattoni G; Ursino F
    Biochem Pharmacol; 1991 Jan; 41(2):177-84. PubMed ID: 1989628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver.
    el Mouelhi M; Didolkar MS; Elias EG; Guengerich FP; Kauffman FC
    Cancer Res; 1987 Jan; 47(2):460-6. PubMed ID: 3024821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of selenium on enzymes metabolizing xenobiotics in rat liver].
    Kravchenko LV; Kuz'mina EE; Avren'eva LI; Pozdniakov AL
    Vopr Med Khim; 1991; 37(5):73-6. PubMed ID: 1759407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in the expression of xenobiotic-metabolizing enzymes during the growth cycle of rat hepatoma cells.
    Krupski G; Kiefer F; Wiebel FJ
    Xenobiotica; 1985; 15(8-9):781-7. PubMed ID: 3934854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary cholesterol-induced changes of xenobiotic metabolism in liver. II. Effects of phenobarbitone and carbon tetrachloride on activities of drug-metabolizing enzymes.
    Hietanen E; Ahotupa M; Heikelä A; Laitinen M
    Drug Nutr Interact; 1982; 1(4):313-27. PubMed ID: 6821390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin.
    Pham MA; Magdalou J; Totis M; Fournel-Gigleux S; Siest G; Hammock BD
    Biochem Pharmacol; 1989 Jul; 38(13):2187-94. PubMed ID: 2500129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models.
    Donato MT; Castell JV; Gómez-Lechón MJ
    J Hepatol; 1999 Sep; 31(3):542-9. PubMed ID: 10488716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lindane treatment on drug metabolizing enzymes and liver weight of CF1 mice in which it evoked hepatomas and in non-susceptible rodents.
    Oesch F; Friedberg T; Herbst M; Paul W; Wilhelm N; Bentley P
    Chem Biol Interact; 1982 May; 40(1):1-14. PubMed ID: 6176340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of single and combined doses of DDT and PCB on drug-metabolizing enzymes in rat liver.
    Parkki MG; Marniemi J; Vainio H
    J Toxicol Environ Health; 1977 Dec; 3(5-6):903-11. PubMed ID: 413932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human adult hepatocytes in primary monolayer culture. Maintenance of mixed function oxidase and conjugation pathways of drug metabolism.
    Grant MH; Burke MD; Hawksworth GM; Duthie SJ; Engeset J; Petrie JC
    Biochem Pharmacol; 1987 Jul; 36(14):2311-6. PubMed ID: 3111481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The toxicity of menadione and mitozantrone in human liver-derived Hep G2 hepatoma cells.
    Duthie SJ; Grant MH
    Biochem Pharmacol; 1989 Apr; 38(8):1247-55. PubMed ID: 2539822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of bile in human Hep G2 cells and in primary cultures of rat hepatocytes.
    Smirthwaite AD; Gaylor JD; Cousins RB; Grant MH
    Artif Organs; 1998 Oct; 22(10):831-6. PubMed ID: 9790080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of enzymes of drug metabolism in rat liver by ultrasound and correction by heparin.
    Legonkova LF; Bushma MI; Zverinsky IV; Eismont KA
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):360-2. PubMed ID: 10445398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of dimethylsulphoxide and 5-aminolaevulinic acid on the activities of cytochrome P450-dependent mixed function oxidase and UDP-glucuronosyl transferase activities in human Hep G2 hepatoma cells.
    Doostdar H; Burke MD; Melvin WT; Grant MH
    Biochem Pharmacol; 1991 Aug; 42(6):1307-13. PubMed ID: 1653569
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-metabolizing enzymes in respiratory nasal mucosa and liver of cynomolgus monkey.
    Longo V; Mazzaccaro A; Ventura P; Gervasi PG
    Xenobiotica; 1992 Apr; 22(4):427-31. PubMed ID: 1523863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat adult hepatocytes in primary pure and mixed monolayer culture. Comparison of the maintenance of mixed function oxidase and conjugation pathways of drug metabolism.
    Niemann C; Gauthier JC; Richert L; Ivanov MA; Melcion C; Cordier A
    Biochem Pharmacol; 1991 Jul; 42(2):373-9. PubMed ID: 1907143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.